摘要
背景:药物发现早期阶段的主要挑战之一是蛋白质-配体结合亲和力的计算评估。机器学习技术有助于预测这种类型的交互。我们可以按照两种方法应用这些技术。首先,使用具有亲和力数据的实验结构。其次,使用蛋白质配体对接模拟。 目标:在这篇综述中,我们描述了最近发表的基于晶体结构的机器学习模型,这些模型可以获得结合亲和力和热力学数据。 方法:我们使用蛋白质数据库中可用的实验结构,并通过 BindingDB、Binding MOAD 和 PDBbind 数据库访问结合亲和力和热力学数据。我们回顾了机器学习模型,以预测使用开源程序(例如 SANDReS 和 Taba)创建的绑定。 结果:对由晶体结构复合物组成的数据集训练的机器学习模型的分析表明,与经典评分函数相比,这些模型具有较高的预测性能。 结论:蛋白质-配体复合物晶体结构数量的快速增加为开发机器学习模型以预测结合亲和力创造了有利的局面。这些模型依赖于来自两个来源的实验数据,结构数据和亲和力数据。实验数据的组合生成了优于经典评分函数的计算模型。
关键词: 晶体结构、机器学习、评分函数空间、结合亲和力、SANDReS、Taba。
Current Medicinal Chemistry
Title:The Impact of Crystallographic Data for the Development of Machine Learning Models to Predict Protein-Ligand Binding Affinity
Volume: 28 Issue: 34
关键词: 晶体结构、机器学习、评分函数空间、结合亲和力、SANDReS、Taba。
摘要:
Background: One of the main challenges in the early stages of drug discovery is the computational assessment of protein-ligand binding affinity. Machine learning techniques can contribute to predicting this type of interaction. We may apply these techniques following two approaches. Firstly, using the experimental structures for which affinity data is available. Secondly, using protein-ligand docking simulations.
Objective: In this review, we describe recently published machine learning models based on crystal structures, for which binding affinity and thermodynamic data are available.
Method: We used experimental structures available at the protein data bank and binding affinity and thermodynamic data was accessed through BindingDB, Binding MOAD, and PDBbind databases. We reviewed machine learning models to predict binding created using open source programs, such as SAnDReS and Taba.
Results: Analysis of machine learning models trained against datasets, composed of crystal structure complexes indicated the high predictive performance of these models when compared with classical scoring functions.
Conclusion: The rapid increase in the number of crystal structures of protein-ligand complexes created a favorable scenario for developing machine learning models to predict binding affinity. These models rely on experimental data from two sources, the structural and the affinity data. The combination of experimental data generates computational models that outperform the classical scoring functions.
Export Options
About this article
Cite this article as:
The Impact of Crystallographic Data for the Development of Machine Learning Models to Predict Protein-Ligand Binding Affinity, Current Medicinal Chemistry 2021; 28 (34) . https://dx.doi.org/10.2174/0929867328666210210121320
DOI https://dx.doi.org/10.2174/0929867328666210210121320 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vitamin D and Vitamin D Receptor Activators in Treatment of Hypertension and Cardiovascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Anti-inflammatory Action of Green Tea
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Can Breast Cancer Stem Cells Evade the Immune System?
Current Medicinal Chemistry Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond
Current Pharmaceutical Design Type 1 11 β-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?
Endocrine, Metabolic & Immune Disorders - Drug Targets Runx1/AML1 is a Guardian of Hematopoietic Stem Cells
Current Cancer Therapy Reviews Matrix Metalloproteinases
Current Medicinal Chemistry Structure-Activity Relationships of Flavonoids
Current Organic Chemistry Recent Advances in Non-Steroidal FXR Antagonists Development for Therapeutic Applications
Current Topics in Medicinal Chemistry Lipid-Activated Nuclear Receptors and Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Bile Acids and Derivatives, Their Nuclear Receptors FXR, PXR and Ligands: Role in Health and Disease and Their Therapeutic Potential
Anti-Cancer Agents in Medicinal Chemistry Endometriosis Management: Workflow on Genomics and Proteomics and Future Biomolecular Pharmacotherapy
Current Medicinal Chemistry Involvement of Leukotriene Pathway in the Pathogenesis of Ischemia- Reperfusion Injury and Septic and Non-Septic Shock
Current Vascular Pharmacology The mTOR Signaling Network: Insights from Its Role During Embryonic Development
Current Medicinal Chemistry The HGF-Met Signaling Axis: Emerging Themes and Targets of Inhibition
Current Protein & Peptide Science Genetics and Molecular Biology of Tuberous Sclerosis Complex
Current Genomics Role of Class II Nuclear Receptors in Liver Carcinogenesis
Anti-Cancer Agents in Medicinal Chemistry The Role of 11Beta-Hydroxysteroid Dehydrogenase in Metabolic Disease and Therapeutic Potential of 11Beta-HSD1 Inhibitors
Current Medicinal Chemistry Pleiotropic Effects of PPARγ Agonist on Hemostatic Activation in Type 2 Diabetes Mellitus
Current Vascular Pharmacology Knocking on FXR's Door:The "Hammerhead"-Structure Series of FXRs Agonists - Amphiphilic Isoxazoles with Potent In Vitro and In Vivo Activities
Current Topics in Medicinal Chemistry